Regulation of inflammatory and lipid metabolism genes by eicosapentaenoic acid-rich oil

Journal of Lipid Research

Volumn 53, Issue 8, 2012, Pages 1679-1689

  Gillies, Peter J ^a   Bhatia, Sujata K ^a   Belcher, Leigh A ^a   Hannon, Daniel B ^b   Thompson, Jerry T ^b   Vanden Heuvel, John P ^b,c  

^a DUPONT COMPANY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c INDIGO Biosciences Inc   (United States)

Author keywords

Fatty acid desaturase; Nuclear receptor; Omega 3 polyunsaturated fatty acid; Peroxisome proliferator activated receptor; Steroyl coenzyme A desaturase

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID RICH OIL; FA DESATURASE 2; FARNESOID X RECEPTOR; LIVER X RECEPTOR; OIL; OLIVE OIL; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FASDS1 GENE; FASDS2 GENE; FATTY ACID METABOLISM; FEMALE; FXR GENE; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; LIPID METABOLISM; LXR GENE; MALE; PPAR ALPHA GENE; PPAR BETA GENE; PPAR GAMMA GENE; PRIORITY JOURNAL; RAR GAMMA GENE; RXR GENE; SCD GENE;

CELL LINE; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; HUMANS; INFLAMMATION; LIPID METABOLISM; OILS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS; TRANSCRIPTOME;

EID: 84863787484     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M022657     Document Type: Article

References (51)

1. Renaud, S., and D. Lanzmann-Petithory. 2001. Coronary heart disease: dietary links and pathogenesis. Public Health Nutr. 4: 459-474. (Pubitemid 32524568)
2. Willett, W. C. 2007. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease. J. Cardiovasc. Med. (Hagerstown). 8 (Suppl.) : 42-45.
3. Hu, F. B., and W. C. Willett. 2002. Optimal diets for prevention of coronary heart disease. J. Am. Med. Assoc. 288: 2569-2578. (Pubitemid 35386892)
4. Calder, P. C. 2003. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids. 38: 343-352. (Pubitemid 36724290)
5. Simopoulos, A. P. 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21: 495-505. (Pubitemid 36026261)
6. Calder, P. C. 2008. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol. Nutr. Food Res. 52: 885-897.
7. Wild, G. E., L. Drozdowski, C. Tartaglia, M. T. Clandinin, and A. B. R. Thomson. 2007. Nutritional modulation of the inflammatory response in inflammatory bowel disease-from the molecular to the integrative to the clinical. World J. Gastroenterol. 13: 1-7. (Pubitemid 46165457)
8. James, M., S. Proudman, and L. Cleland. 2010. Fish oil and rheumatoid arthritis: past, present and future. Proc. Nutr. Soc. 69: 316-323.
9. Schulman, I. G. 2010. Nuclear receptors as drug targets for metabolic disease. Adv. Drug Deliv. Rev. 62: 1307-1315.
10. Beaven, S. W., and P. Tontonoz. 2006. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu. Rev. Med. 57: 313-329. (Pubitemid 43261994)
11. Sampath, H., and J. M. Ntambi. 2005. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu. Rev. Nutr. 25: 317-340. (Pubitemid 41209005)
12. Francis, G. A., E. Fayard, F. Picard, and J. Auwerx. 2003. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 65: 261-311. (Pubitemid 38249155)
13. Torres C. F., H. S. Garcia, J. J. Ries, and J. Charles G. Hill. 2001. Esterification of glycerol with conjugated linoleic acid and long-chain fatty acids from fish oil. J. Am. Oil Chem. Soc. 78: 1093-1098. (Pubitemid 34125339)
14. Zhang, J., J. A. Grieger, P. M. Kris-Etherton, J. T. Thompson, P. J. Gillies, J. A. Fleming, and J. P. Vanden Heuvel. 2011. Walnut oil increases cholesterol efflux through inhibition of stearoyl CoA desaturase 1 in THP-1 macrophage-derived foam cells. Nutr. Metab. (Lond). 8: 61.
15. Otokozawa, S., M. Ai, B. F. Asztalos, C. C. White, S. Demissie-Banjaw, L. A. Cupples, K. Nakajima, P. W. F. Wilson, and E. J. Schaefer. 2010. Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study. Atherosclerosis. 213: 251-255.
16. Ai, M., S. Otokozawa, B. F. Asztalos, Y. Ito, K. Nakajima, C. C. White, L. A. Cupples, P. W. Wilson, and E. J. Schaefer. 2010. Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study. Clin. Chem. 56: 967-976.
17. Dewailly, E., C. Blanchet, S. Gingras, S. Lemieux, and B. J. Holub. 2002. Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am. J. Clin. Nutr. 76: 85-92. (Pubitemid 34686553)
18. Asztalos, B. F., L. A. Cupples, S. Demissie, K. V. Horvath, C. E. Cox, M. C. Batista, and E. J. Schaefer. 2004. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 24: 2181-2187. (Pubitemid 39482449)
19. Bouwens, M., O. van de Rest, N. Dellschaft, M. G. Bromhaar, L. C. P. G. M. de Groot, J. M. Geleijnse, M. Müller, and L. A. Afman. 2009. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am. J. Clin. Nutr. 90: 415-424.
20. Radonjic, M., M. J. van Erk, W. J. Pasman, H. M. Wortelboer, H. F. J. Hendriks, and B. van Ommen. 2009. Effect of body fat distribution on the transcription response to dietary fat interventions. Genes Nutr. 4: 143-149.
21. Flachs, P., O. Horakova, P. Brauner, M. Rossmeisl, P. Pecina, N. Franssen-van Hal, J. Ruzickova, J. Sponarova, Z. Drahota, C. Vlcek, et al. 2005. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia. 48: 2365-2375. (Pubitemid 41618929)
22. Hammamieh, R., N. Chakraborty, S-A. Miller, E. Waddy, M. Barmada, R. Das, S. A. Peel, A. A. Day, and M. Jett. 2007. Differential effects of omega-3 and omega-6 fatty acids on gene expression in breast cancer cells. Breast Cancer Res. Treat. 101: 7-16. (Pubitemid 47555330)
23. Narayanan, B. A., N. K. Narayanan, and B. S. Reddy. 2001. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int. J. Oncol. 19: 1255-1262.
24. Duda, M. K., K. M. O'Shea, and W. C. Stanley. 2009. Omega-3 poly-unsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential. Cardiovasc. Res. 84: 33-41.
25. Tanaka, N., X. Zhang, E. Sugiyama, H. Kono, A. Horiuchi, T. Nakajima, H. Kanbe, E. Tanaka, F. J. Gonzalez, and T. Aoyama. 2010. Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice. Biochem. Pharmacol. 80: 1601-1612.
26. Kjaer, M. A., A. Vegusdal, T. Gjøen, A. C. Rustan, M. Todorcevi, and B. Ruyter. 2008. Effect of rapeseed oil and dietary n-3 fatty acids on triacylglycerol synthesis and secretion in Atlantic salmon hepatocytes. Biochim. Biophys. Acta. 1781: 112-122.
27. Skulas-Ray, A. C., S. G. West, M. H. Davidson, and P. M. Kris- Etherton. 2008. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin. Pharmacother. 9: 1237-1248. (Pubitemid 351721760)
28. Skulas-Ray, A. C., P. M. Kris-Etherton, W. S. Harris, J. P. Vanden Heuvel, P. R. Wagner, and S. G. West. 2011. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am. J. Clin. Nutr. 93: 243-252.
29. Ide, T. 2005. Interaction of fish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue. Diabetes. 54: 412-423.
30. Muhlhausler, B. S., R. Cook-Johnson, M. James, D. Miljkovic, E. Duthoit, and R. Gibson. Opposing effects of omega-3 and omega- 6 long chain polyunsaturated fatty acids on the expression of lipogenic genes in omental and retroperitoneal adipose depots in the rat. J. Nutr. Metab. Epub ahead of print. August 5, 2010; doi:10.1155/2010/927836.
31. Cohen, P., and J. M. Friedman. 2004. Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1). J. Nutr. 134: 2455S-2463S. (Pubitemid 39201621)
32. Velliquette, R. A., P. J. Gillies, P. M. Kris-Etherton, J. W. Green, G. Zhao, and J. P. Vanden Heuvel. 2009. Regulation of human stearoyl-CoA desaturase by omega-3 and omega-6 fatty acids: implications for the dietary management of elevated serum triglycerides. J. Clin. Lipidol. 3: 281-288.
33. Zhang, J., P. M. Kris-Etherton, J. T. Thompson, D. B. Hannon, P. J. Gillies, and J. P. Vanden Heuvel. 2012. Alpha-linolenic acid increases cholesterol efflux in macrophage-derived foam cells by decreasing stearoyl CoA desaturase 1 expression: evidence for a farnesoid-X-receptor mechanism of action. J. Nutr. Biochem. 23: 400-409. PubMed
34. Tu, W. C., R. J. Cook-Johnson, M. J. James, B. S. Mühlhäusler, and R. A. Gibson. 2010. Omega-3 long chain fatty acid synthesis is regulated more by substrate levels than gene expression. Prostaglandins Leukot. Essent. Fatty Acids. 83: 61-68.
35. Jenkins, D. J., C. W. Kendall, E. Vidgen, S. Agarwal, A. V. Rao, R. S. Rosenberg, E. P. Diamandis, R. Novokmet, C. C. Mehling, T. Perera, et al. 1999. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am. J. Clin. Nutr. 69: 395-402. (Pubitemid 29104558)
36. Henning, S. M., W. Aronson, Y. Niu, F. Conde, N. H. Lee, N. P. Seeram, R. P. Lee, J. Lu, D. M. Harris, A. Moro, et al. 2006. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J. Nutr. 136: 1839-1843. (Pubitemid 43973585)
37. Singhal, R., T. M. Badger, and M. J. Ronis. 2007. Reduction in 7,12-dimethylbenz[a]anthracene-induced hepatic cytochrome- P450 1A1 expression following soy consumption in female rats is mediated by degradation of the aryl hydrocarbon receptor. J. Nutr. 137: 19-24. (Pubitemid 46052853)
38. Gebauer, S. K., T. L. Psota, W. S. Harris, and P. M. Kris-Etherton. 2006. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am. J. Clin. Nutr. 83 (Suppl.): 1526-1535.
39. Hihi, A. K., L. Michalik, and W. Wahli. 2002. PPARs: transcriptional effectors of fatty acids and their derivatives. Cell. Mol. Life Sci. 59: 790-798. (Pubitemid 34628240)
40. Montagner, A., G. Rando, G. Degueurce, N. Leuenberger, L. Michalik, and W. Wahli. 2011. New insights into the role of PPARs. Prostaglandins Leukot. Essent. Fatty Acids. 85:
41. Wahli, W. 2002. Peroxisome proliferator-activated receptors (PPARs): from metabolic control to epidermal wound healing. Swiss Med. Wkly. 132: 83-91. (Pubitemid 34492280)
42. Peters, J. M., S. S. Lee, W. Li, J. M. Ward, O. Gavrilova, C. Everett, M. L. Reitman, L. D. Hudson, and F. J. Gonzalez. 2000. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol. Cell. Biol. 20: 5119-5128. (Pubitemid 30431565)
43. Spiegelman, B. M. 1997. Peroxisome proliferator-activated receptor gamma: a key regulator of adipogenesis and systemic insulin sensitivity. Eur. J. Med. Res. 2: 457-464.
44. Latruffe, N., and J. Vamecq. 1997. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochimie. 79: 81-94. (Pubitemid 27290347)
45. Cowart, L. A., S. Wei, M-H. Hsu, E. F. Johnson, M. U. Krishna, J. R. Falck, and J. H. Capdevila. 2002. The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator- activated receptor ligands. J. Biol. Chem. 277: 35105-35112.
46. Krey, G., O. Braissant, F. L'Horset, E. Kalkhoven, M. Perroud, M. G. Parker, and W. Wahli. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11: 779-791. (Pubitemid 27225305)
47. Yu, K., W. Bayona, C. B. Kallen, H. P. Harding, C. P. Ravera, G. McMahon, M. Brown, and M. A. Lazar. 1995. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270: 23975-23983.
48. Coleman, J. D., K. S. Prabhu, J. T. Thompson, P. S. Reddy, J. M. Peters, B. R. Peterson, C. C. Reddy, and J. P. Vanden Heuvel. 2007. The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator- activated receptor-beta/delta (PPARbeta/delta). Free Radic. Biol. Med. 42: 1155-1164. (Pubitemid 46428510)
49. Sapieha, P., A. Stahl, J. Chen, M. R. Seaward, K. L. Willett, N. M. Krah, R. J. Dennison, K. M. Connor, C. M. Aderman, E. Liclican, et al. 2011. 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci. Transl. Med. 3: 69ra12.
50. Groeger, A. L., C. Cipollina, M. P. Cole, S. R. Woodcock, G. Bonacci, T. K. Rudolph, V. Rudolph, B. A. Freeman, and F. J. Schopfer. 2010. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat. Chem. Biol. 6: 433-441.
51. de Urquiza, A. M., S. Liu, M. Sjoberg, R. H. Zetterstrom, W. Griffiths, J. Sjovall, and T. Perlmann. 2000. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science. 290: 2140-2244.